PTPRU
Basic information
Region (hg38): 1:29236516-29326813
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PTPRU gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 16 | 19 | ||||
missense | 87 | 92 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 3 | 3 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 87 | 18 | 6 |
Variants in PTPRU
This is a list of pathogenic ClinVar variants found in the PTPRU region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-29236635-C-A | PTPRU-related disorder | Likely benign (Sep 17, 2024) | ||
1-29255340-G-A | not specified | Uncertain significance (Dec 19, 2023) | ||
1-29255382-C-T | not specified | Uncertain significance (Sep 16, 2021) | ||
1-29255383-G-A | not specified | Uncertain significance (Feb 28, 2024) | ||
1-29255394-G-C | not specified | Uncertain significance (Jul 25, 2023) | ||
1-29258558-G-C | not specified | Uncertain significance (Oct 03, 2022) | ||
1-29258561-A-G | not specified | Uncertain significance (Jul 06, 2022) | ||
1-29258624-C-T | not specified | Uncertain significance (Dec 20, 2023) | ||
1-29258629-C-T | PTPRU-related disorder | Likely benign (Aug 15, 2019) | ||
1-29258677-C-T | PTPRU-related disorder | Benign (Nov 26, 2019) | ||
1-29258715-A-C | not specified | Uncertain significance (Jul 25, 2023) | ||
1-29258717-G-A | not specified | Uncertain significance (Apr 13, 2023) | ||
1-29258733-A-C | not specified | Uncertain significance (Jan 22, 2024) | ||
1-29259313-A-G | not specified | Uncertain significance (Jun 02, 2023) | ||
1-29259504-C-T | PTPRU-related disorder | Likely benign (Feb 17, 2023) | ||
1-29259505-G-T | not specified | Uncertain significance (Aug 02, 2021) | ||
1-29259513-C-A | not specified | Uncertain significance (Dec 22, 2023) | ||
1-29259521-T-C | not specified | Uncertain significance (Jun 06, 2022) | ||
1-29259881-G-A | PTPRU-related disorder | Benign (Oct 28, 2019) | ||
1-29259961-G-A | not specified | Uncertain significance (Aug 02, 2021) | ||
1-29260025-C-T | PTPRU-related disorder | Likely benign (Nov 12, 2019) | ||
1-29260618-A-G | not specified | Uncertain significance (Oct 27, 2022) | ||
1-29260621-C-T | not specified | Uncertain significance (Jul 19, 2023) | ||
1-29260674-G-T | not specified | Uncertain significance (Oct 17, 2023) | ||
1-29260700-A-G | not specified | Uncertain significance (Dec 15, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PTPRU | protein_coding | protein_coding | ENST00000345512 | 31 | 90298 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.393 | 0.607 | 125704 | 0 | 44 | 125748 | 0.000175 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.45 | 725 | 936 | 0.775 | 0.0000624 | 9373 |
Missense in Polyphen | 282 | 395.68 | 0.7127 | 3798 | ||
Synonymous | 0.793 | 364 | 384 | 0.949 | 0.0000258 | 2916 |
Loss of Function | 6.23 | 17 | 75.3 | 0.226 | 0.00000414 | 789 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000210 | 0.000210 |
Ashkenazi Jewish | 0.000298 | 0.000298 |
East Asian | 0.000167 | 0.000163 |
Finnish | 0.0000955 | 0.0000924 |
European (Non-Finnish) | 0.000240 | 0.000237 |
Middle Eastern | 0.000167 | 0.000163 |
South Asian | 0.0000980 | 0.0000980 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Tyrosine-protein phosphatase which dephosphorylates CTNNB1. Regulates CTNNB1 function both in cell adhesion and signaling. May function in cell proliferation and migration and play a role in the maintenance of epithelial integrity. May play a role in megakaryocytopoiesis. {ECO:0000269|PubMed:10397721, ECO:0000269|PubMed:12501215, ECO:0000269|PubMed:16574648}.;
- Pathway
- EPO Receptor Signaling;Signal Transduction;KitReceptor;Signaling by SCF-KIT;Signaling by Receptor Tyrosine Kinases
(Consensus)
Recessive Scores
- pRec
- 0.134
Intolerance Scores
- loftool
- 0.366
- rvis_EVS
- -1.78
- rvis_percentile_EVS
- 2.28
Haploinsufficiency Scores
- pHI
- 0.346
- hipred
- Y
- hipred_score
- 0.782
- ghis
- 0.531
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.938
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ptpru
- Phenotype
- vision/eye phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);
Gene ontology
- Biological process
- protein dephosphorylation;cell adhesion;transmembrane receptor protein tyrosine phosphatase signaling pathway;negative regulation of cell population proliferation;cell differentiation;negative regulation of cell migration;animal organ regeneration;homotypic cell-cell adhesion;protein localization to cell surface;peptidyl-tyrosine dephosphorylation;response to glucocorticoid;negative regulation of canonical Wnt signaling pathway;positive regulation of cell-cell adhesion mediated by cadherin
- Cellular component
- plasma membrane;integral component of plasma membrane;cell-cell junction
- Molecular function
- protein tyrosine phosphatase activity;transmembrane receptor protein tyrosine phosphatase activity;protein binding;beta-catenin binding